Anne Daub is a Partner on the Therapeutics team, and joined the Firm in 2024. Prior to Deerfield, Ms. Daub was a Vice President and Biotechnology Senior Analyst for T. Rowe Price for more than five years. Before this, she was a Senior Analyst at Soros Fund Management LLC and Citadel LLC. Prior to these roles, Ms. Daub was an Analyst at Visium Asset Management for eight years and also held positions at Bear Stearns & Co., Integrated Finance Ltd. and J.P. Morgan Securities Inc. She holds a graduate degree in Finance from H.E.C Graduate School of Management in Paris, France.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.
Read MoreInvestment
Supporting companies across the healthcare ecosystem with flexible funding models…
Read MoreFeatured
Deerfield Management Announces $25M Grant from New York State and Empire State Development to Build a Lab of the Future at Healthcare Innovation Campus, Cure® Washington University and Deerfield Management Launch VeritaScience to Drive Drug Discovery Deerfield Foundation Awards More Than $1.4 Million to Improve Health, Accelerate Innovation and Promote Equity Sfunga Therapeutics and Deerfield Management Announce Publication on Novel Antifungal SF001 in NaturePortfolio Companies
Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Read More View Portfolio CompaniesResearch Collaborations
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.
Read More View Research CollaborationsStrategic Partners
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
Read MoreDeerfield Foundation
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.
Read More Meet the Foundation TeamFoundation Partners by Focus
Children's Health Diversity Initiatives Maternal Health View AllFounded Diversity Programs
Break into the Boardroom Fellowships Women in ScienceCure Campus
Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.
Read More Join the Cure Email ListCure Programming
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.
Events at the CureBrian Chow, Ph.D.
Brian Chow, Ph.D., is a Principal on the Therapeutics team and joined the Firm in 2022. Prior to Deerfield, Dr. Chow spent 10 years at the University of Pennsylvania, most recently as an Associate Professor of Bioengineering. Before that, he was the Head of Research Operations and Alliances for Sage Therapeutics and a Venture Associate at Third Rock Ventures. Dr. Chow holds a B.S. in Chemistry from Stanford University and a Ph.D. in Media Arts and Sciences from the Massachusetts Institute of Technology.